Eva Yin, PhD, MPH

Eva F. Yin, PhD, MPH, JD, is a partner in Wilson Sonsini Goodrich & Rosati’s FDA & healthcare regulatory practice. She advises life sciences companies at all stages of growth, including medical device, digital health, pharmaceutical, diagnostic, cosmetic, dietary supplement, and general wellness companies. Her areas of focus include providing strategic regulatory counseling; assisting companies with their go-to-market strategies and FDA regulatory pathways; regulatory review of clinical trial, research use, and commercial contracts, informed consents, advertising and promotional materials; assisting companies with their healthcare compliance program policies and procedures and risk assessment of business arrangements and fee structures under federal and state healthcare fraud and abuse laws; regulatory due diligence in diverse corporate transactions; and assisting manufacturers with their reporting obligations under the Sunshine Act.